Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Janus Henderson Investors

Tracked across 12 events · 504 articles · First seen Apr 02, 2026 · Last active Aug 21, 2026

Sentiment
9
Attention
10
Events
12
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Janus Henderson Investors is acquiring Rantum Capital to expand its private markets capabilities in Europe, particularly in the DACH region, and to build out its pan-European private credit platform. This acquisition is part of its broader strategy to diversify into high-demand areas and amplify existing strengths.
Jun 09, 2026 · 9 articles
2 -10
Regulatory
Morgan Stanley, through its subsidiary Morgan Stanley — Morgan Stanley & Company LLC, has increased its voting rights in STRATEC SE, a German medical technology company, crossing the 10% threshold on 15 July 2026. The…
Impact: Janus Henderson Investors reduced its stake in STRATEC SE to zero, following a go-private transaction and group restructuring. This represents a complete exit from the company, which may be seen as a slight negative signal but is part of a broader restructuring.
Jul 08, 2026 · 20 articles
2 -10
Business
Alzchem Group AG, a German specialty chemicals company, has undergone a significant ownership restructuring. Janus Henderson Investors and its subsidiary Janus Henderson Group — Janus Henderson UK (Holdings) Limited have reduced their stakes in Alzchem…
Impact: Janus Henderson Investors reduced its stake in Alzchem to zero as part of the go-private transaction, exiting its investment.
Aug 12, 2026 · 8 articles
4 70
Business
Werewolf Therapeutics and Ambros Therapeutics announced a definitive all-stock merger agreement to create a combined company focused on advancing neridronate, Ambros' late-stage treatment for Complex Regional Pain Syndrome Type 1 (CRPS-1). The combined company will…
Impact: Janus Henderson Investors co-led the private placement, providing capital to fund neridronate's development. This investment aligns with their healthcare-focused strategy and is expected to benefit from the potential approval of neridronate.
Aug 21, 2026 · 6 articles
4 -20
Business
Impact: Portfolio manager Richard Clode called for SK Hynix to increase returns to at least 80% of free cash flow.
Aug 06, 2026 · 8 articles
4 10
Business
Impact: Janus Henderson Investors is a current Obsidian Therapeutics, Inc. investor participating in the private placement financing.
Apr 14, 2026 · 7 articles
8 0
International
Impact: Janus Henderson Investors is the employer of Sat Duhra, a portfolio manager who commented on India's economic challenges.
May 19, 2026 · 35 articles
10 0
International
Impact: Janus Henderson Investors provides analysis on India's structural challenges and the impact of the energy shock on growth and government finances.
May 05, 2026 · 374 articles
4 5
Business
Impact: Janus Henderson Investors Plc is being acquired by Trian Partners and General Catalyst, reflecting the ongoing consolidation and strategic investments within the asset management sector.
Jun 03, 2026 · 17 articles
4 0
Business
Apr 29, 2026 · 8 articles
8 0
Business
May 10, 2026 · 6 articles
2 0
Business
Apr 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Janus Henderson Investors live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.